Literature DB >> 21674262

Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.

Dimitrios Psachoulias1, Maria Vertzoni, Konstantinos Goumas, Vasilios Kalioras, Stefania Beato, James Butler, Christos Reppas.   

Abstract

PURPOSE: To evaluate precipitation in and supersaturation of intestinal contents after administration of pharmacologically relevant doses of dipyridamole and ketoconazole to 12 healthy adults.
METHODS: On two separate days each subject was administered in stomach 240 ml aqueous solutions of two dipyridamole doses (30/90 mg) and two ketoconazole doses (100/300 mg). Physicochemical characteristics, total drug content, and drug concentration were measured in individual intestinal contents (≤7 ml) aspirated at specific times post-dosing. Drug concentration after incubation (37°C/48 h) and equilibrium solubility were measured. Precipitate crystallinity was evaluated by x-ray powder diffraction.
RESULTS: Precipitated fraction was minimal (dipyridamole, ≤7%) or limited (ketoconazole, ≤16%). Ketoconazole precipitates were mostly amorphous. Depending on dose, intestinal contents with pH > 3.6 were supersaturated with dipyridamole up to 10 and 30 min and with ketoconazole up to 30 and 50 min post-administration. Intestinal contents with pH > 5 and concentration of micellar components <5 mM were supersaturated with ketoconazole or dipyridamole, but precipitated fraction was significant only for ketoconazole. After incubation, crystalline precipitates were found in almost all samples. Slow precipitation of base and/or precipitation of other phases account for this observation.
CONCLUSIONS: Intralumenal precipitation of weakly alkaline, lipophilic, high permeability drugs may not be substantial. Estimating intestinal supersaturation in regard to free base is inadequate as other phases may precipitate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674262     DOI: 10.1007/s11095-011-0506-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.

Authors:  Edmund S Kostewicz; Martin Wunderlich; Ulrich Brauns; Robert Becker; Thomas Bock; Jennifer B Dressman
Journal:  J Pharm Pharmacol       Date:  2004-01       Impact factor: 3.765

2.  Drug supersaturation in simulated and human intestinal fluids representing different nutritional states.

Authors:  Jan Bevernage; Joachim Brouwers; Sarah Clarysse; Maria Vertzoni; Jan Tack; Pieter Annaert; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2010-11       Impact factor: 3.534

3.  Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir.

Authors:  Joachim Brouwers; Jan Tack; Frank Lammert; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

4.  Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.

Authors:  F Tian; F Zhang; N Sandler; K C Gordon; C M McGoverin; C J Strachan; D J Saville; T Rades
Journal:  Eur J Pharm Biopharm       Date:  2006-12-13       Impact factor: 5.571

Review 5.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

Authors:  Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

6.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

7.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

8.  Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.

Authors:  Lida Kalantzi; Eva Persson; Britta Polentarutti; Bertil Abrahamsson; Konstantinos Goumas; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

9.  Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.

Authors:  Maria Vertzoni; Helen Archontaki; Christos Reppas
Journal:  J Lipid Res       Date:  2008-08-07       Impact factor: 5.922

10.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states.

Authors:  S Clarysse; J Tack; F Lammert; G Duchateau; C Reppas; P Augustijns
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

View more
  25 in total

1.  Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug.

Authors:  Ajit S Narang; Sherif Badawy; Qingmei Ye; Dhaval Patel; Maria Vincent; Krishnaswamy Raghavan; Yande Huang; Aaron Yamniuk; Balvinder Vig; John Crison; George Derbin; Yan Xu; Antonio Ramirez; Michael Galella; Frank A Rinaldi
Journal:  Pharm Res       Date:  2015-02-28       Impact factor: 4.200

2.  An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.

Authors:  Dimitrios Psachoulias; Maria Vertzoni; James Butler; David Busby; Moira Symillides; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2012-08-14       Impact factor: 4.200

3.  Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.

Authors:  Chara Litou; Dimitrios Psachoulias; Maria Vertzoni; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2020-01-27       Impact factor: 4.200

4.  Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults.

Authors:  Christos Reppas; Eleni Karatza; Constantinos Goumas; Constantinos Markopoulos; Maria Vertzoni
Journal:  Pharm Res       Date:  2015-05-22       Impact factor: 4.200

5.  Dissolution Testing in Drug Product Development: Workshop Summary Report.

Authors:  Andreas Abend; David Curran; Jesse Kuiper; Xujin Lu; Hanlin Li; Andre Hermans; Pramod Kotwal; Dorys A Diaz; Michael J Cohen; Limin Zhang; Erika Stippler; German Drazer; Yiqing Lin; Kimberly Raines; Lawrence Yu; Carrie A Coutant; Haiyan Grady; Johannes Krämer; Sarah Pope-Miksinski; Sandra Suarez-Sharp
Journal:  AAPS J       Date:  2019-01-28       Impact factor: 4.009

6.  Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling.

Authors:  Andy Z X Zhu; Ming-Chih David Ho; Christopher K Gemski; Bei-Ching Chuang; Mingxiang Liao; Cindy Q Xia
Journal:  AAPS J       Date:  2016-09-06       Impact factor: 4.009

7.  Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Stuart Mudge; David Hayes; Richard N Upton
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

8.  Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.

Authors:  Ahmed Elkhabaz; Sreya Sarkar; Garth J Simpson; Lynne S Taylor
Journal:  Pharm Res       Date:  2019-10-30       Impact factor: 4.200

9.  Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.

Authors:  Chara Litou; Maria Vertzoni; Constantinos Goumas; Vassilis Vasdekis; Wei Xu; Filippos Kesisoglou; Christos Reppas
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

Review 10.  The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.

Authors:  Jamal Khan; Thomas Rades; Ben Boyd
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.